You have access
Should Upfront Therapy With Androgen Receptor Signaling Inhibitors Be Used in All Japanese Patients With Metastatic Castration-sensitive Prostate Cancer?
KENTA ONISHI, YASUSHI NAKAI, MAKITO MIYAKE, YOSHIAKI MATSUMURA, MIKIKO ONISHI, KEIICHI SAKAMOTO, SHUNSUKE HAJIKANO, YUSUKE IEMURA, MASAKI HARAMOTO, FUMISATO MAESAKA, SHUYA HIRAO, TAKANORI YOSHIDA, KUNIAKI INOUE, TOSHIHISA SAKA, TAKASHI IWAMOTO, YUKINARI HOSOKAWA, KOTA IIDA, YOSHITAKA ITAMI, KIYOHIDE FUJIMOTO and NOBUMICHI TANAKA
Anticancer Research December 2025, 45 (12) 5595-5607; DOI: https://doi.org/10.21873/anticanres.17894